Bone Medical completes merger with Revenir

By Melissa Trudinger
Monday, 23 August, 2004

UK biotech company Bone Limited has completed its merger with Perth-based listed property management company Revenir (ASX: REV) after a successful capital raising of $2.5 million closed oversubscribed earlier in the month.

The company, which will be known as Bone Medical, is expected to start trading on August 31, 2004 under the stock symbol BNE.

Oxytocin analogue treats chronic abdominal pain

Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...

'Low-risk' antibiotic linked to rise of dangerous superbug

A new study has challenged the long-held belief that rifaximin — commonly prescribed to...

Robotic hand helps cultivate baby corals for reef restoration

The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...

Content from other channels on our network

Flow control for optimising growth of microorganisms

Funding boost to cut cotton industry's emissions

Aust partnership leads to solar-powered canola

Making the national electricity market fit for purpose

Driving progress in clean energy

FWLHD launches chronic wound care clinic

Rising healthcare facility demands pave way for innovation

Designs unveiled for the new Melton Hospital

AIA Australia launches virtual mental health service

Depressive disorders: 70% of Australians not getting adequate treatment

Over-the-air vulnerabilities discovered in Advantech EKI access points

Tasmanian Government seeks input on advanced technology strategy

CSIRO electrolyser pilot a success at Bluescope Steel

Three states announce BESS projects in a week

Emerson offers solution to reduce energy costs and emissions